Abliva AB (publ) Stock Forecast, Price & News

0.00 (-0.92 %)
(As of 07/30/2021 09:47 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume100 shs
Average Volume7,022 shs
Market Capitalization$29.04 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NEVPF News and Ratings via Email

Sign-up to receive the latest news and ratings for Abliva AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Abliva AB (publ) logo

About Abliva AB (publ)

Abliva AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. Its projects include KL1333 AND NV354. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.88 out of 5 stars

Medical Sector

1729th out of 2,221 stocks

Pharmaceutical Preparations Industry

742nd out of 869 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Abliva AB (publ) (OTCMKTS:NEVPF) Frequently Asked Questions

What stocks does MarketBeat like better than Abliva AB (publ)?

Wall Street analysts have given Abliva AB (publ) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Abliva AB (publ) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Abliva AB (publ)?

Abliva AB (publ) saw a drop in short interest in July. As of July 15th, there was short interest totaling 10,300 shares, a drop of 40.8% from the June 30th total of 17,400 shares. Based on an average trading volume of 9,300 shares, the short-interest ratio is presently 1.1 days.
View Abliva AB (publ)'s Short Interest

When is Abliva AB (publ)'s next earnings date?

Abliva AB (publ) is scheduled to release its next quarterly earnings announcement on Friday, August 20th 2021.
View our earnings forecast for Abliva AB (publ)

How has Abliva AB (publ)'s stock been impacted by Coronavirus?

Abliva AB (publ)'s stock was trading at $0.0796 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NEVPF shares have increased by 35.3% and is now trading at $0.1077.
View which stocks have been most impacted by COVID-19

Who are Abliva AB (publ)'s key executives?

Abliva AB (publ)'s management team includes the following people:
  • Ellen k. Donnelly, Chief Executive Officer
  • Catharina Jz Johansson, Chief Financial Officer & VP-Communications
  • Eskil Elmér, Chief Scientific Officer & Manager-Research
  • Magnus Hansson, Chief Medical Officer & VP-Preclinical Development
  • Mark Farmery, Vice President-Business Development

Who are some of Abliva AB (publ)'s key competitors?

What is Abliva AB (publ)'s stock symbol?

Abliva AB (publ) trades on the OTCMKTS under the ticker symbol "NEVPF."

How do I buy shares of Abliva AB (publ)?

Shares of NEVPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abliva AB (publ)'s stock price today?

One share of NEVPF stock can currently be purchased for approximately $0.11.

How much money does Abliva AB (publ) make?

Abliva AB (publ) has a market capitalization of $29.04 million and generates $20,000.00 in revenue each year.

How many employees does Abliva AB (publ) have?

Abliva AB (publ) employs 7 workers across the globe.

What is Abliva AB (publ)'s official website?

The official website for Abliva AB (publ) is www.neurovive.com.

Where are Abliva AB (publ)'s headquarters?

Abliva AB (publ) is headquartered at MEDICON VILLAGE SCHEELEVAGEN 2, LUND V7, 22381.

How can I contact Abliva AB (publ)?

Abliva AB (publ)'s mailing address is MEDICON VILLAGE SCHEELEVAGEN 2, LUND V7, 22381. The company can be reached via phone at (646) 275-6220 or via email at [email protected]

This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.